A surge of a neural-specific protein in the brain is the earliest-yet biomarker for Alzheimer’s disease, report University of Illinois Urbana-Champaign researchers studying a mouse model of the disease. Furthermore, the increased protein activity leads to the seizures associated with the earliest...

What do a synthetic chemist, a medical imaging expert, and a neurologist have in common? They’re coming together in the Biomedical Imaging Center at the Beckman Institute for Advanced Science and Technology to develop better diagnostic tools and...

Neurodegenerative disorders such as Alzheimer’s disease affect more than 270 million people worldwide. Alheimer's is the leading cause of dementia, resulting in memory loss due to atrophy of neurons in the hippocampus, which is the part of the brain that regulates learning and memory. Nanoparticles...

Researchers at the Beckman Institute, with help from the Champaign Public Library, investigated the potential benefits of reading in improving memory. They found that regular, engaged leisure reading can strengthen memory skills in older adults, laying the groundwork for better practices in...

Interdisciplinary researchers at the Beckman Institute, including Molecular & Integrative Physiology Professor Dan Llano, received federal funding to develop ultrasound imaging methods for studying the neurovascular changes underlying Alzheimer's disease. Their low-cost, widely accessible...

Researchers at the Beckman Institute developed a technique for producing super-resolution ultrasound images of tissue microvasculature in just a fraction of the time previously needed. Their work could enable future research into the neurovascular mechanisms behind conditions like Alzheimer’s...

A new study by researchers at the University of Illinois Urbana-Champaign suggests the overexpression of a particular gene could serve as a risk factor for Alzheimer’s disease. Their findings could also lead to better understandings of the links between Alzheimer’s disease, Fragile X Syndrome, and...

Researchers at Carle Illinois College of Medicine have uncovered new evidence about hearing loss in patients with Alzheimer’s Disease (AD). It pinpoints unexpected areas of brain shrinkage in AD patients with hearing loss. The work could eventually lead to earlier intervention and new treatment...

Dr. Tsai’s lab focuses on understanding the molecular mechanisms underlying neuronal excitability imbalance in neurological and psychiatric disorders including epilepsy and autism.

Professor Daniel Llano is a neurologist at the Carle Neuroscience Institute and has been a faculty member in the MIP department since 2010. He obtained his BS, PhD, and MD at UIUC before moving to Massachusetts to pursue his clinical training at Harvard Medical School. He later became a post-...